We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
W.W. Grainger
GWW
$63.5B
| $919K | 0.02% |
4,275
+1,456
| +52% | +$327K |
2013 Q2
9 quarters
|
|
|
RSPP
277
DELISTED
RSP Permian, Inc.
RSPP
| $916K | 0.02% |
45,252
+9,677
| +27% | +$228K |
2015 Q1
2 quarters
|
|
278
Invesco Water Resources ETF
PHO
$1.98B
| $899K | 0.02% |
43,756
-2,399
| -5% | -$54.9K |
2013 Q2
9 quarters
|
|
279
DELISTED
Treehouse Foods
THS
| $892K | 0.02% |
11,470
-4,415
| -28% | -$354K |
2014 Q1
6 quarters
|
|
280
Old Dominion Freight Line
ODFL
$39.5B
| $884K | 0.02% |
43,485
-553,494
| -93% | -$12.6M |
2014 Q3
4 quarters
|
|
281
Vanguard Morningstar Mid-Cap ETF
VO
$107B
| $878K | 0.02% |
30,100
+200
| +0.7% | +$6.24K |
2014 Q1
6 quarters
|
|
282
iShares Russell 1000 ETF
IWB
$49.2B
| $875K | 0.02% |
8,174
-21
| -0.3% | -$2.38K |
2013 Q2
9 quarters
|
|
|
BSTC
283
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $866K | 0.02% |
19,880
-8,155
| -29% | -$440K |
2014 Q1
6 quarters
|
|
284
ICICI Bank
IBN
$108B
| $864K | 0.02% |
113,373
-19,860
| -15% | -$170K |
2014 Q1
6 quarters
|
|
285
Xencor
XNCR
$1.75B
| $863K | 0.02% |
70,555
+2,600
| +4% | +$50.9K |
2014 Q3
4 quarters
|
|
286
Phillips 66
PSX
$117B
| $860K | 0.02% |
11,194
+59
| +0.5% | +$4.69K |
2013 Q2
9 quarters
|
|
287
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.25B
| $859K | 0.02% |
+19,214
| New | +$892K |
2015 Q3
0 quarters
|
|
288
Las Vegas Sands
LVS
$24.8B
| $856K | 0.02% |
22,531
-1,000
| -4% | -$50.4K |
2013 Q2
9 quarters
|
|
289
Southern Copper
SCCO
$172B
| $855K | 0.02% |
34,930
+8,456
| +32% | +$212K |
2015 Q2
1 quarter
|
|
290
Monster Beverage
MNST
$90.9B
| $853K | 0.02% |
75,780
+3,324
| +5% | +$39K |
2014 Q4
3 quarters
|
|
291
NextEra Energy
NEE
$167B
| $851K | 0.02% |
34,896
-540
| -2% | -$13.7K |
2013 Q2
9 quarters
|
|
292
Dover
DOV
$26.5B
| $842K | 0.02% |
18,237
-743
| -4% | -$37.6K |
2013 Q2
9 quarters
|
|
293
G-III Apparel Group
GIII
$1.23B
| $841K | 0.02% |
13,640
+6,120
| +81% | +$420K |
2015 Q1
2 quarters
|
|
294
Incyte
INCY
$23B
| $820K | 0.02% |
7,433
+450
| +6% | +$50.5K |
2015 Q1
2 quarters
|
|
295
Netflix
NFLX
$297B
| $810K | 0.02% |
78,490
-29,800
| -28% | -$320K |
2015 Q2
1 quarter
|
|
296
Baxter International
BAX
$13.4B
| $806K | 0.02% |
24,549
-50,017
| -67% | -$1.89M |
2013 Q2
9 quarters
|
|
297
Weyerhaeuser
WY
$14.2B
| $796K | 0.02% |
29,112
-2,425
| -8% | -$71.6K |
2014 Q1
6 quarters
|
|
|
EXAM
298
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $796K | 0.02% |
27,221
+9,855
| +57% | +$340K |
2013 Q3
8 quarters
|
|
299
Palo Alto Networks
PANW
$291B
| $783K | 0.02% |
27,300
-17,400
| -39% | -$513K |
2014 Q1
6 quarters
|
|
300
Berkshire Hathaway Class A
BRK.A
$1.14T
| $781K | 0.02% |
4
+1
| +33% | +$206K |
2014 Q3
4 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.